ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Hot Features

Registration Strip Icon for alerts Register for real-time alerts, custom portfolio, and market movers

BGP Berkeley Scot

22.59
0.00 (0.00%)
Last Updated: 01:00:00
Delayed by 15 minutes
Share Name Share Symbol Market Type Share ISIN Share Description
Berkeley Scot LSE:BGP London Ordinary Share GB00B03W5P29 ORD 2P
  Price Change % Change Share Price Bid Price Offer Price High Price Low Price Open Price Shares Traded Last Trade
  0.00 0.00% 22.59 - 0.00 01:00:00
Industry Sector Turnover Profit EPS - Basic PE Ratio Market Cap
0 0 N/A 0

Berkeley Scott Share Discussion Threads

Showing 1051 to 1069 of 1275 messages
Chat Pages: 51  50  49  48  47  46  45  44  43  42  41  40  Older
DateSubjectAuthorDiscuss
07/2/2002
19:39
Does anyone know what effect the potential buy out is going to have on the stock price as it seats at the moment?
xnews
07/2/2002
11:45
All gone a bit quiet again, anyone got opinions on deal with quintiles, or with a third party whoever they may be. And what has the sale of bristol myers squib got to do with bioglan.
dryboy
05/2/2002
18:56
Does the CEO of Enron have one arm and go by the name of Richard Kimble ?
stampcoverman
05/2/2002
17:06
For a bust company, there seems to be a lot of 'Buys' going on. Anybody know why ?
stampcoverman
04/2/2002
11:14
Suspect we'll see Deutsche dump the rest of their holding at whatever they can get.
Only 2.5 million to go!
Wonder who's buying them??

wetdream
04/2/2002
10:13
I haven't watched Coronation Street since 1964, so I doubt if I would find much time to watch 'Einstein TV'.

Anyway, we all know that the only thing worth watching is Star Trek..................make it so number one.......engage.

stampcoverman
04/2/2002
07:11
Found this over the w/e, possibly the best 2002 recovery share.
easyramp
03/2/2002
23:53
Yes, it must be worth it for Mr.Sadler to do something for the share holders seeing as he has most to lose.

I would like to know if there is any real chance of Bioglan reducing any of its debt mountain by its own turnover (without any outside help), even if it takes a long time.

stampcoverman
02/2/2002
00:21
what planet are you guys on? if the level of the offer was equal to the comapanies debt, shareholders would get nothing.

the RNS is saying that it looks likely that if an offer was made then it would be for a nominal value, probably a few pence.

dr biotech
01/2/2002
21:53
if somebody sells somebody else buys, so somebody bought 1000000 shares at 7p there still is hope, if they pay 113 million they can pay 8/10 million more to satisfy shareholders that by now thing they lost everyting hense 10p .
terropol
01/2/2002
20:42
Ironic thing was that ADVFN showed the 1m trade as a buy!
Lesson 1 - never trust the trade info.

wetdream
01/2/2002
19:18
sod it i cant find the switch, and mali7 has nicked the last life jacket.
lovegod
01/2/2002
17:51
LONDON (AFX) - A Bioglan Pharma PLC share issue would probably create some
share price weakness, but this would represent a strong buying opportunity,
according to WestLB Panmure analyst Emma Palmer.
A press report that Bioglan's institutional shareholders are putting
pressure on the company to make a 200 mln stg share issue to fund the
acquisition of Bristol-Myers Squibb's skin-care arm saw Bioglan's shares fall to
390 pence at the outset.
By 11.04 am, however, the stock had rallied to show a gain of a 1/2 at 398
as dealers adopted a more positive stance on a possible share issue.
The 484 mln stg acquisition would give the company a much bigger presence in
the US and turn it into one of the UK's largest independent drugs companies. The
company's plan to finance the deal via increased borrowing, however, has
triggered worries about the resulting high level of debt.
Since the deal has not yet been finalised -- and there are no guarantees
that it will happen -- there are no details and any comments made are
speculative, said Palmer.
However, since the number of shares needed for the suggested 200 mln usd
upfront payment would increase issued capital by a third at present levels, the
analyst expects there to be some price weakness and believes that this
represents a strong buying opportunity.
An initial payment of 200 mln usd would increase gearing to 167 pct from the
current level of 60 pct. The press rumours suggest that institutional investors
are unhappy with this level of gearing and are instead pressurising the company
to issue new shares.
fjb/jsa


For more information and to contact AFX: www.afxnews.com and www.afxpress.com


Bioglan Pharma(BGP) GB0004342670
C(p) -1.25 C(%) -19.231 C 5.25 B 5.0 O 5.5 H 6.25 L 4.75 Op 5.75 V 3,238,599 T close A

GOOD CALL EMMA.

sjc
01/2/2002
17:13
Latest RNS confirms that the ship is, glug,glug,indeed sinking!
Deutsche sold 1m @7p - and they should know!
Last one to leave please turn out the lights..

wetdream
01/2/2002
16:17
i think we all need a nice cuppa tea
rioleatapas
01/2/2002
15:57
The shares are still trading and the price is down. What exactly about this does anybody not understand?
If the news was good the price would rise
If the news is bad the price will fall
This does not take a rocket scientist!

salpara111
01/2/2002
15:31
Can't really see the point of Quintiles buying Bioglan lock stock and barrel - they're a thrid party CRO and a CSO - not a manufacturing co.
They might be keen to expand into marketing where margins are higher(hence SKP's Solaraze in the US) but they've no pharma products of their own.
So a 30% stake would make more sense.

wetdream
01/2/2002
14:31
I think what they get is a 30% stake in a growing company. Bioglan are only in a mess because their debt is too high. If Quintiles or any other 3rd party has got spare cash, this company has got long term growth prospects.
stampcoverman
01/2/2002
14:19
Again, what is in that for Quintiles? If they can pick up the whole company for the cost of the debt, why would they agree to effectively subsidise the private shareholders by paying off debt? You need to think about this from their perspective, not ours. They really don't care whether we are happy or not, they simply want a reasonable business (which Bioglan is when the debt is removed) for as little money as possible. Much like us, in fact.

Paul DSP

paul dsp
Chat Pages: 51  50  49  48  47  46  45  44  43  42  41  40  Older

Your Recent History

Delayed Upgrade Clock